ABBV+18.09%33.3%
CRBP-66.43%33.3%
SKYE-98.52%33.3%
As of Oct 9, 2026, 4:27 AM ET
GLP-1 Long '24: Pharma Constituents
AbbVie Inc.ABBV | 33.3% | 0.39% | 2.31% | 8.57% | 4.81% | 19.23% | 17.38% | 32.76% | 18.09% | 43.62% | 180.50% | $481.31B |
Corbus Pharmaceuticals Holdings, Inc.CRBP | 33.3% | -4.01% | -23.84% | -40.52% | -16.88% | -35.26% | -38.51% | 1.35% | -66.43% | -73.08% | -82.94% | $97.6M |
Skye Bioscience, Inc.SKYE | 33.3% | 1.82% | 1.22% | -26.92% | 1.86% | -72.84% | -72.66% | -85.75% | -98.52% | -56.59% | -92.36% | $7.4M |
| Theme return | — | -0.60% | -6.77% | -19.86% | -3.63% | -45.67% | -49.86% | -35.51% | -70.97% | -67.00% | -60.40% | — |
| Average | 33.3% | -0.60% | -6.77% | -19.62% | -3.40% | -29.62% | -31.26% | -17.21% | -48.95% | -28.68% | 1.73% | $160.47B |
| Median | 33.3% | 0.39% | 1.22% | -26.92% | 1.86% | -35.26% | -38.51% | 1.35% | -66.43% | -56.59% | -82.94% | $97.6M |
| Std Dev | 0.0% | 2.48% | 12.08% | 20.69% | 9.61% | 37.80% | 37.11% | 50.13% | 49.18% | 51.57% | 126.47% | $226.87B |
| Min | 33.3% | -4.01% | -23.84% | -40.52% | -16.88% | -72.84% | -72.66% | -85.75% | -98.52% | -73.08% | -92.36% | $7.4M |
| Max | 33.3% | 1.82% | 2.31% | 8.57% | 4.81% | 19.23% | 17.38% | 32.76% | 18.09% | 43.62% | 180.50% | $481.31B |
| % Positive Tickers | 66.67% | 66.67% | 33.33% | 66.67% | 33.33% | 33.33% | 66.67% | 33.33% | 33.33% | 33.33% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort